Breathe BioMedical
Breathe BioMedical is a privately held Canadian health-technology company in Moncton that develops a breath-analysis platform for non-invasive cancer screening, currently operating at an early stage with 11–50 employees.
- Company typePrivate
- Founded-
- HeadquartersMoncton, Canada
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Breathe BioMedical does
Breathe BioMedical is a privately held Canadian health-technology company headquartered in Moncton, New Brunswick, that describes its offering as a technology platform for cancer screening through breath analysis. The company's value proposition, as captured in firmographics, is non-invasive cancer detection via exhaled breath, positioning it in the breathomics / liquid-biopsy-adjacent diagnostics category rather than imaging or blood-based screening.
The firm operates with a headcount in the 11–50 range and is at an early commercial stage. The source materials did not surface product-level detail — no sensor architecture, biomarker panel, clinical validation results, regulatory submissions, or named partner institutions were disclosed. The company website returned only a loading/verification page at the time of scraping, so technical and commercial specifics are not verifiable from the input. No certifications, patents, partnerships, leadership team, customers, or pricing information were available.
No revenue, pricing model, or go-to-motion data were disclosed. The financial figures in the source (EBITDA, operating income, net income reported in the trillions of dollars) are not credible for an 11–50-person startup and appear to be data extraction errors rather than actual reported results; they should not be relied upon. As a result, revenue mechanics, customer segments, and contract economics cannot be characterized with any confidence from this dataset.
Breathe BioMedical firmographics
Firmographics- Name
- Breathe BioMedical
- Website
- https://breathebiomedical.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Breathe BioMedical is a privately held Canadian health-technology company in Moncton that develops a breath-analysis platform for non-invasive cancer screening, currently operating at an early stage with 11–50 employees.
- Ownership category
- akta.pro rank
Breathe BioMedical industry classification
Industry- Product category
- Cancer Diagnostics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
- akta.pro secondary industry
- Pulmonary Function Testing (PFT) & Respiratory Diagnostics (HLAKANAC)
Keywords
Where Breathe BioMedical is headquartered
LocationHeadquarters
- HQ city
- Moncton
- HQ country
- Canada
- HQ region
- North America
Markets served
Breathe BioMedical business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations
Breathe BioMedical product offering
Product offeringCore offering
Breathe BioMedical is a technology platform that provides cancer screening through breath analysis. The company analyzes breath samples using its proprietary biomedical platform to enable non-invasive detection of cancer, offering an alternative to traditional tissue biopsy or imaging-based screening methods.
Differentiator
Problem solved
Functional benefit
Products and services
- Cancer Screening via Breath Analysis Platform A technology platform that performs cancer screening by analyzing breath samples, offered to healthcare providers, clinical laboratories, and cancer screening programs as a non-invasive alternative to traditional diagnostic methods.
Companies that use Breathe BioMedical
Customer profileIdeal customer profiles1 record
Breathe BioMedical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Breathe BioMedical competitors and assessment
Company assessmentEmerging players
- Aethon Medical: Aethon is pursuing breath-based biomarker detection for lung cancer, a direct indication overlap with Breathe BioMedical's cancer-screening focus.
- Cairn Diagnostics: Cairn Diagnostics develops breath-based diagnostic tests for metabolic and GI conditions, sharing the breath-sample collection and analysis model used by Breathe BioMedical.
- Bioserenity: Bioserenity focuses on connected diagnostic and monitoring solutions including breath-related respiratory diagnostics, making it a comparable emerging player in non-invasive diagnostic technology.
- Exhalation Technology (e.g., Sensity AI): Sensity AI applies AI to volatile organic compound (VOC) analysis from breath, sharing the machine-learning-on-breath-signals approach underpinning many cancer-screening platforms.
Broad incumbents
- GRAIL: GRAIL is the leading multi-cancer early-detection company (Galleri test) and represents the dominant non-invasive screening competitor that any breath-based cancer platform must position against.
- Thermo Fisher Scientific (Diagnostics): Thermo Fisher's diagnostics segment provides mass spectrometry and lab services that underpin clinical biomarker detection, including breath biomarker workflows; a broad incumbent that could partner with or acquire niche players like Breathe BioMedical.
Direct peers
- Menssana Research: Menssana Research pioneered clinical breath-testing for disease detection, sharing the core value proposition of non-invasive breath-based diagnostics with Breathe BioMedical.
- Owlstone Medical: Owlstone Medical is the leading commercial-stage developer of breath-based diagnostics ('Breath Biopsy') for cancer and other diseases, making it the closest direct competitor and most comparable peer to Breathe BioMedical.
- Xhale: Xhale develops breath-based diagnostic and monitoring technologies, overlapping directly with Breathe BioMedical's breath-analysis modality.
- Avisa Diagnostics: Avisa is developing breath-based biomarker tests for detecting pulmonary and other infections, directly overlapping with Breathe BioMedical's breath-analysis diagnostic approach.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights4 records
Customer concentration
Breathe BioMedical social profiles
Digital presenceBreathe BioMedical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Breathe BioMedical leadership team
Management profileNumber of profiles
Breathe BioMedical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Breathe BioMedical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Breathe BioMedical
What does Breathe BioMedical do?
Breathe BioMedical is a technology platform that provides cancer screening through breath analysis. The company analyzes breath samples using its proprietary biomedical platform to enable non-invasive detection of cancer, offering an alternative to traditional tissue biopsy or imaging-based screening methods.
Is Breathe BioMedical a public or private company?
Breathe BioMedical is a private company. It is classified as unknown and is currently operating.
When was Breathe BioMedical founded?
Breathe BioMedical was founded in -1. It employs 11 to 50 people.
Where is Breathe BioMedical based?
Breathe BioMedical is headquartered in Moncton, Canada, in the North America region.
Who are Breathe BioMedical's main competitors?
Emerging players on record are Aethon Medical, Cairn Diagnostics, Bioserenity and Exhalation Technology (e.g., Sensity AI). Broad incumbents are GRAIL and Thermo Fisher Scientific (Diagnostics). Direct peers are Menssana Research, Owlstone Medical, Xhale and Avisa Diagnostics.
Does Breathe BioMedical have an API?
No public API is recorded for Breathe BioMedical.
What industry is Breathe BioMedical in?
Breathe BioMedical's product category is Cancer Diagnostics. Its primary akta.pro industry code is HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry), with a secondary code of HLAKANAC, Pulmonary Function Testing (PFT) & Respiratory Diagnostics. Its NAICS code is 621511 and its SIC code is 8071.